Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magrolimab (The Univ. of Texas)
- Development stage
- Unknown
- Lead developer
- The University of Texas
- Modality
- Antibody-Based Therapeutics
01
Overview
Magrolimab (The Univ. of Texas): sourced facts only. name: "Magrolimab is a monoclonal antibody directed against the macrophage checkpoint CD47 on myeloid leukemia cells that was preclinically synergistic with azacitidine-venetoclax, warranting further clinical evaluation." [PMID:40198272]; target: "Magrolimab is a monoclonal antibody directed against the macrophage checkpoint CD47 on myeloid leukemia cells that was preclinically synergistic with azacitidine-venetoclax, warranting further clinical evaluation." [PMID:40198272]; developer: "Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas." [PMID:40198272]; modality: "Magrolimab is a monoclonal antibody directed against the macrophage checkpoint CD47 on myeloid leukemia cells that was preclinically synergistic with azacitidine-venetoclax, warranting further clinical evaluation." [PMID:40198272]
02
Targets
CD47 (Cluster of Differentiation 47)
Beyond the preview
Go deeper on Magrolimab (The Univ. of Texas).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Magrolimab (The Univ. of Texas).